ROYAL BANK OF CANADA - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 26 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q1 2021$017
+1600.0%
0.00%
Q4 2020$010.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q1 2021
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 39,820$119,0000.02%
Westside Investment Management, Inc. 8$00.00%
American Portfolios Advisors 23$690.00%
JPMORGAN CHASE & CO 78$00.00%
ROYAL BANK OF CANADA 17$00.00%
VANGUARD GROUP INC 72,791$217,0000.00%
UBS Group AG 23,459$70,0000.00%
Sowell Financial Services LLC 19$00.00%
OSAIC HOLDINGS, INC. 15$00.00%
BANK OF AMERICA CORP /DE/ 138$00.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders